Heart disease. Gene suggests asthma drugs may ease cardiovascular inflammation.
D058927:5-Lipoxygenase-Activating Proteins; D000818:Animals; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001094:Arachidonate 5-Lipoxygenase / Q000235:genetics / Q000378:metabolism; D001161:Arteriosclerosis / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002352:Carrier Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics* / Q000378:metabolism; D002882:Chromosomes, Human, Pair 13; D002986:Clinical Trials as Topic; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D006801:Humans; D007249:Inflammation; D020024:Leukotriene Antagonists; D015289:Leukotrienes / Q000096:biosynthesis / Q000378:metabolism; D008565:Membrane Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics* / Q000378:metabolism; D009203:Myocardial Infarction / Q000235:genetics* / Q000517:prevention & control; D018077:Receptors, Leukotriene / Q000378:metabolism; D012307:Risk Factors; D020521:Stroke / Q000235:genetics*
D058927:5-Lipoxygenase-Activating Proteins; C548592:ALOX5AP protein, human; D018927:Anti-Asthmatic Agents; D002352:Carrier Proteins; D020024:Leukotriene Antagonists; D015289:Leukotrienes; D008565:Membrane Proteins; D018077:Receptors, Leukotriene; D001094:Arachidonate 5-Lipoxygenase